Armata Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1996
Net Income	-69.05	-36.92	-23.16	-22.18	-19.48	-16.7	-12.84	-24.28	-10.79	21.82	Upgrade
Depreciation & Amortization	0.97	0.89	1.17	1.11	1.35	1.35	0.34	0.34	0.3	0.13	Upgrade
Share-Based Compensation	0.94	3.11	2.88	3.48	4.27	0.05	0.7	2	0.48	1.94	Upgrade
Other Operating Activities	19.71	0.44	-4.47	-0.68	-1.73	4.68	2.6	5.9	-10.05	-37.74	Upgrade
Operating Cash Flow	-47.42	-32.48	-23.58	-18.27	-15.58	-10.63	-9.19	-10.61	-9.78	-12.57	Upgrade
Capital Expenditures	-8.13	-2.21	-1.3	-0.82	-0.13	-0.81	-0.06	-0.28	-0.21	-1.2	Upgrade
Acquisitions	0	0	0	0	3.01	0	0	0	0	0	Upgrade
Change in Investments	0	0	0	0	0	9.62	0	0	0	0	Upgrade
Investing Cash Flow	-8.13	-2.21	-1.3	-0.82	2.88	8.81	-0.06	-0.28	-0.21	-1.2	Upgrade
Dividends Paid	0	0	0	0	0	0	0	-0.08	0	0	Upgrade
Share Issuance / Repurchase	0.01	44.52	26.93	23.06	9.98	0	9.49	7.58	12.78	0	Upgrade
Debt Issued / Paid	54.03	0	0	0.72	0	0	-0.82	-0.1	0	0	Upgrade
Other Financing Activities	-0.04	-0.5	-1.41	-0.57	-1	-	-	-0.17	-	-	Upgrade
Financing Cash Flow	53.99	44.02	25.52	23.21	8.98	0	8.67	7.23	12.78	0	Upgrade
Net Cash Flow	-1.57	9.32	0.64	4.12	-3.73	-1.81	-0.58	-3.66	2.79	-13.77	Upgrade
Free Cash Flow	-55.56	-34.69	-24.88	-19.09	-15.71	-11.44	-9.25	-10.89	-9.99	-13.77	Upgrade
Free Cash Flow Margin	-1226.69%	-629.85%	-556.08%	-2320.05%	-	-	-8043.48%	-4186.54%	-2103.37%	-3367.73%	Upgrade
Free Cash Flow Per Share	-1.54	-1.01	-1.03	-1.16	-2.01	-2.46	-20.27	-154.89	-258.49	-514.69	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).